Fibrobiologics, Inc.

FBLGCIK 0001958777 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Mar 13, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0019

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 6, 2026no items parsed May 5, 2026no items parsed May 1, 2026no items parsed Apr 20, 2026no items parsed Apr 17, 2026no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Fibrobiologics, Inc.

Name	Roles	Filings
Coen Stacy Ann	Director	2
Hoffman Robert E.	Director	2
Link Matthew	Director	2
Niklas Victoria Ninon Olivia	Director	2

Showing 6-9 of 9

Per pagePrevPage 2 of 2

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Fibrobiologics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	O'Heeron Pete	4	25%	-42.3%	-85.7%	+88.5%	-86.4%
2	Khoja Hamid	3	33%	-7.4%	-24.8%	+88.5%	-86.0%

All filings

32 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
May 4, 2026	Garcia Ruben A General Counsel	Holdings only	-	-	-
May 4, 2026	Davis Jason Chief Financial Officer	Holdings only	-	-	-
May 4, 2026	Khoja Hamid Chief Scientific Officer	Holdings only	-	-	-
May 4, 2026	O'Heeron Pete CHIEF EXECUTIVE OFFICER · Director	Holdings only	-	-	-
Mar 5, 2026	Khoja Hamid Chief Scientific Officer	PPurchase	30,000	$0.38	$11,400

Showing 1-5 of 32

Per pagePage 1 of 7Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value